HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Halima Gamrani Selected Research

Glycosaminoglycans

12/2022Flaxseed extract reduces tissue accumulation and enhances urinary excretion of chondroitin sulphate in the rat: a possible new path in substrate reduction therapy for mucopolysaccharidosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Halima Gamrani Research Topics

Disease

8Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 06/2017
5Dehydration (Water Stress)
10/2012 - 02/2011
4Wounds and Injuries (Trauma)
05/2021 - 08/2018
4Mental Disorders (Mental Disorder)
05/2021 - 01/2017
4Parkinson Disease (Parkinson's Disease)
08/2018 - 01/2011
3Acute Liver Failure (Fulminant Hepatic Failure)
01/2022 - 06/2012
2Body Weight (Weight, Body)
05/2021 - 03/2016
2Neoplasms (Cancer)
01/2021 - 01/2021
2Hepatic Encephalopathy
11/2012 - 07/2012
1Mucopolysaccharidoses
12/2022
1Mucopolysaccharidosis IV (Morquio Syndrome)
12/2022
1Communicable Diseases (Infectious Diseases)
01/2021
1COVID-19
01/2021
1Gliosis
01/2021
1Brain Death (Brain Dead)
06/2020
1Motor Disorders
12/2019
1Brain Injuries (Brain Injury)
12/2019
1Anxiety Disorders (Anxiety Disorder)
01/2019
1Parkinsonian Disorders (Parkinsonism)
11/2017
1Liver Diseases (Liver Disease)
07/2012
1Coma (Comas)
07/2012
1Brain Edema (Cerebral Edema)
06/2012
1Hypothermia
06/2012

Drug/Important Bio-Agent (IBA)

5CurcuminIBA
01/2021 - 03/2016
4Heavy MetalsIBA
05/2021 - 06/2017
4MetalsIBA
01/2021 - 08/2018
3Anti-Anxiety Agents (Anxiolytics)IBA
05/2021 - 10/2012
3CopperIBA
08/2018 - 06/2017
2Thioacetamide (Thioacetamid)IBA
01/2022 - 01/2019
2graphene oxideIBA
01/2021 - 01/2021
2GraphiteIBA
01/2021 - 01/2021
2AluminumIBA
01/2021 - 01/2011
2Neuroprotective AgentsIBA
12/2019 - 11/2017
2ElectrolytesIBA
10/2012 - 07/2012
2NeurosteroidsIBA
07/2012 - 06/2012
2Vasopressins (Vasopressin)IBA
04/2012 - 02/2011
1ChondroitinIBA
12/2022
1GlycosaminoglycansIBA
12/2022
1Serotonin AgentsIBA
05/2021
1Pharmaceutical PreparationsIBA
01/2021
1VaccinesIBA
01/2021
1Antiviral Agents (Antivirals)IBA
01/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021
1SolutionsIBA
01/2021
1Dehydroepiandrosterone SulfateIBA
06/2020
1ManganeseIBA
12/2019
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
12/2019
1Phospholipids (Phosphatides)FDA LinkGeneric
12/2019
1Docosahexaenoic AcidsIBA
12/2019
1Therapeutic UsesIBA
06/2019
1curcumin IIIIBA
06/2019
1ElementsIBA
08/2018
1Trace Elements (Biometals)IBA
01/2017
1Serotonin (5 Hydroxytryptamine)IBA
10/2012
1EnzymesIBA
07/2012
1nibentan (HE 11)IBA
07/2012
1CatecholaminesIBA
07/2012
1Pregnanolone (Allopregnanolone)IBA
07/2012
1GABA-A Receptors (GABA(A) Receptor)IBA
07/2012
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
07/2012
1Dopamine (Intropin)FDA LinkGeneric
07/2012
1BenzodiazepinesIBA
06/2012
1Messenger RNA (mRNA)IBA
05/2011
1Pro-Opiomelanocortin (Proopiomelanocortin)IBA
05/2011

Therapy/Procedure

1Therapeutics
12/2022
1Ligation
11/2012
1Fluid Therapy (Oral Rehydration Therapy)
04/2012